Regen BioPharma, Inc. (OTCMKTS:RGBP – Get Free Report) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 1,854,604 shares, an increase of 445.6% from the May 31st total of 339,948 shares. Based on an average trading volume of 64,500,748 shares, the days-to-cover ratio is presently 0.0 days.
Regen BioPharma Stock Performance
Regen BioPharma has a 12 month low of $0.00 and a 12 month high of $0.12.
About Regen BioPharma
Regen BioPharma, Inc is a development‐stage biotechnology company focused on advancing regenerative medicine and immunotherapy products through stem cell science. The company’s research efforts center on identifying and developing novel therapeutic candidates that harness the regenerative potential of adult and embryonic stem cells, with an emphasis on cancer, infectious and autoimmune diseases.
Its primary activities include the discovery and preclinical validation of stem cell‐derived receptors and peptides, the development of immuno‐oncology assets, and the filing of investigational new drug (IND) applications to support first‐in‐human studies.
Featured Articles
- Five stocks we like better than Regen BioPharma
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Receive News & Ratings for Regen BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Regen BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
